NCT03988231 2021-10-08Enoxaparin Versus Placebo for Venous Thromboembolism Prevention in Low Risk Cancer Patients After Surgical Procedures: a Randomized, Double Blind, Placebo Controlled Clinical Trial Pilot StudyUniversity of UtahPhase 4 Withdrawn
NCT00966277 2016-12-12Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer PatientsM.D. Anderson Cancer CenterPhase 4 Completed87 enrolled 9 charts